HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Variant genotyping of CCR2-64I, SDF1-3' A and CCR5Delta32 in HIV-1 infected Chinese long-term nonprogressors].

AbstractBACKGROUND:
To investigate variant genotyping of CCR2-64I, SDF1-3'A and CCR5Delta32 in HIV-1 infected Chinese Long-term nonprogressors and to study their association with disease progression.
METHODS:
The genotypes of CCR2-64I, SDF1-3'A and CCR5Delta32 were detected by polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) assay in seventeen HIV-1 infected Chinese Long-term nonprogressors (LTNPs) and thirty-nine Chinese typical progressors (TPs).
RESULTS:
The frequency of CCR2-64I and SDF1-3'A in LTNPs are 50% and 62.5%, higher than those (23.08% and 33.33%) in TPs. Only one heterozygous CCR5 mutant was detected in LTNPs, and no CCR5 mutant in TPs.
CONCLUSION:
Variant genotyping of CCR2-64ISDF1-3'A and CCR5Delta32 may be protective factors for delaying disease progression in HIV-1 infected Chinese LTNPs.
AuthorsShu-xiang Wang, Hong Shang, Xiao-xu Han, Zi-ning Zhang, Ya-nan Wang, Min Zhang, Yong-jun Jiang, Jing Liu, Yan-li Su
JournalZhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology (Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi) Vol. 20 Issue 1 Pg. 16-9 (Mar 2006) ISSN: 1003-9279 [Print] China
PMID16642210 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CXCL12
  • Receptors, CCR2
  • Receptors, CCR5
  • Receptors, HIV
Topics
  • Chemokine CXCL12 (genetics)
  • China
  • Gene Frequency
  • Genotype
  • HIV Infections (genetics, pathology, virology)
  • HIV Long-Term Survivors
  • HIV-1 (physiology)
  • Host-Pathogen Interactions
  • Humans
  • Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Receptors, CCR2 (genetics)
  • Receptors, CCR5 (genetics)
  • Receptors, HIV (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: